Genotyping Assay Market will Approximated to be USD 73.9 Billion in Advance of 2035; Market is improved due to Increasing Genetic Research & Disease Diagnostics

Download Sample

Published Date: April 2025

Genotyping Assay market is the industry focused on the development, manufacturing, and use of tests or assays to analyze and identify genetic variations within an individual's DNA. These assays are crucial for determining genetic differences, mutations, and markers that can influence health, disease susceptibility, drug response, and various other biological traits. Ongoing research in genomics and the increasing prevalence of genetic diseases are driving the demand for genotyping assays, is projected to growth of target market.

Segmentation Analysis:

By Offering	Reagents & Kits, Instruments, Software, and Services
By Techniques	Microarray, DNA Sequencing, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, and Others
By Application	Genetic Disease Diagnosis, Forensic Analysis, Pharmacogenomics, Agriculture, and Others
By End-User	Diagnostics & Research Laboratories, Academic Institutes, Pharmaceutical & Biotechnological Companies, and Others

Report Highlights:

Genotyping Assay market size is attributed by USD 22.3 Billion in 2025.
The target market size is expected to increase at a rate of USD 73.9 Billion by 2035, and growing at a CAGR of 14.1%.
By offering, reagents and kits segment hold the major share in genotyping assay market.
Based on techniques, PCR segment dominates in genotyping assay market.
The genotyping assay market is dominated by genetic disease diagnosis segment in application segment.
The research & academic institutes is growing at highest CAGR in the target market.
North America hold the major share in genotyping assay market.
Europe is second leading region in the market.

Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Growing Government and Healthcare Investment	Regulatory and Ethical Challenges	Advancement of Precision Medicine

Key Highlights

In April 2024, Bio-Rad launched multiplexed digital PCR assay for breast cancer mutation detection, known as ddPLEX ESr1 Mutation Detection Kit. The assay aimed to give highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring. This new kit provides oncology researchers with technologies that enables biomarker discovery and clinical trials, which improves patient monitoring.

Report Analysis:

·Custom TaqMan SNP Genotyping Assays:

The Custom TaqMan SNP Genotyping Assays offer a tailored solution for researchers needing single nucleotide polymorphism (SNP) genotyping assays based on specific sequence information. These custom assays are designed, synthesized, and delivered as quality-controlled primer and probe sets for SNP genotyping, allowing researchers to explore genetic variations that may not be covered by existing assays. All custom-designed assays are thoroughly tested and undergo stringent analytical quality control to ensure they meet the high standards required for accurate and reproducible results

Browse ∼40 market data tables and ∼35 figures through ∼170 slides and in-depth TOC on “Genotyping Assay Market, Size, Share, By Offerings (Reagents & Kits, Instruments, Software, and Services), Techniques (Microarray, DNA Sequencing, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, and Others), Application (Genetic Disease Diagnosis, Forensic Analysis, Pharmacogenomics, Agriculture, and Others), End-User (Diagnostics & Research Laboratories, Academic Institutes, Pharmaceutical & Biotechnological Companies, and Others), and Region - Trends, Analysis, and Forecast till 2035”

Segmentation:

By Offering:

Reagents and Kits
Instruments
Software
Services

By Techniques

Microarray
DNA Sequencing
Polymerase Chain Reaction (PCR)
Mass Spectrometry
Electrophoresis
Others

By Application:

Genetic Disease Diagnosis
Forensic Analysis
Pharmacogenomics
Agriculture
Others

By End-User:

Diagnostics & Research Laboratories
Academic Institutes
Pharmaceutical & Biotechnological Companies
Others

By Region:

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa

For more insights into the Genotyping Assay Market and its future trends, visit link below:https://www.prophecymarketinsights.com/market_insight/Global-Genotyping-Assay-Market-By-3873

Competitive Landscape of Genotyping Assay Market:

The key players operating the genotyping assay market include Illumina, Inc, QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc, GE Healthcare, Standard BioTools, Adaptive Biotechnologies, Oxford Nanopore Technologies plc, F. Hoffmann-La Roche Ltd, PerkinElmer, Twist Biosciences, Bio-Rad Laboratories, Inc, Macrogen, Inc., Eurofins Scientific.